-
-
-
-
-
-
-
Pluristem Therapeutics (PSTI) Preliminary Data from COVID-19 Compassionate Use Program, Treating Seven Patients with Acute Respiratory Failure
-
-
-
-
-
-
-
Pluristem Therapeutics (PSTI) Secures Orphan Drug Designation for Its PLX-R18 Cell Therapy
-
-
-
-
-
55,531 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All